Security using authentication
The UK is now facing a significant problem in how it secures the country’s medicines’ supply chain after leaving the EU on 1 January 2021. But rather than view this as an insurmountable problem, FarmaTrust is calling on the UK government to be true to its word and deliver new Brexit benefits.
Sensing Covid risk
Covid-19 was an unpredictable so-called black swan event in 2020 and the second wave in Europe indicates we might need to live with the pandemic for a long time. Although the development of vaccines is a breakthrough, the impact of vaccination will be slow to materialise.
AI & microfluidics
Microfluidic technologies are rapidly becoming the method of choice for micro- and nanoparticle production across a number of sectors, from cell biology research to drug development. This approach offers a number of advantages over traditional batch methods, including precise process control, enhanced reliability, and the ability to easily scale up production. Read more in C&I Magazine.